William Blair Investment Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-980,662
Closed -$241M 418
2022
Q3
$241M Buy
980,662
+2,504
+0.3% +$676K 0.95% 19
2022
Q2
$242M Buy
978,158
+64,350
+7% +$17.4M 0.9% 20
2022
Q1
$303M Sell
913,808
-110,140
-11% -$33.9M 0.9% 21
2021
Q4
$368M Buy
1,023,948
+61,601
+6% +$20.8M 0.99% 13
2021
Q3
$313M Buy
962,347
+29,774
+3% +$10.1M 0.88% 26
2021
Q2
$291M Sell
932,573
-4,583
-0.5% -$1.41M 0.91% 31
2021
Q1
$299M Buy
937,156
+370,442
+65% +$119M 0.97% 20
2020
Q4
$184M Sell
566,714
-1,496
-0.3% -$414K 0.61% 62
2020
Q3
$157M Sell
568,210
-7,932
-1% -$2.29M 0.61% 62
2020
Q2
$139M Buy
576,142
+205,340
+55% +$41.2M 0.57% 70
2020
Q1
$53.8M Sell
370,802
-274,035
-42% -$45.5M 0.26% 110
2019
Q4
$110M Sell
644,837
-103,970
-14% -$19.3M 0.44% 76
2019
Q3
$133M Sell
748,807
-66,717
-8% -$14.4M 0.57% 57
2019
Q2
$212M Buy
815,524
+629,455
+338% +$167M 0.89% 25
2019
Q1
$53.1M Buy
186,069
+58,242
+46% +$19.4M 0.22% 110
2018
Q4
$41.5M Sell
127,827
-139,450
-52% -$48.4M 0.21% 118
2018
Q3
$120M Sell
267,277
-16,097
-6% -$6.35M 0.42% 81
2018
Q2
$116M Sell
283,374
-425,957
-60% -$154M 0.43% 69
2018
Q1
$206M Sell
709,331
-253,536
-26% -$64.3M 0.79% 31
2017
Q4
$180M Buy
962,867
+18,006
+2% +$3.36M 0.7% 34
2017
Q3
$159M Sell
944,861
-28,933
-3% -$4.38M 0.57% 50
2017
Q2
$140M Sell
973,794
-147,223
-13% -$19.8M 0.51% 61
2017
Q1
$140M Buy
1,121,017
+91,651
+9% +$10.6M 0.53% 58
2016
Q4
$116M Buy
1,029,366
+272,428
+36% +$31.6M 0.46% 74
2016
Q3
$97.3M Sell
756,938
-56,433
-7% -$6.76M 0.37% 85
2016
Q2
$88.9M Buy
813,371
+415
+0.1% +$41.3K 0.35% 94
2016
Q1
$77.1M Buy
812,956
+3,524
+0.4% +$297K 0.31% 108
2015
Q4
$73.1M Buy
809,432
+151,090
+23% +$12.8M 0.3% 113
2015
Q3
$61.1M Buy
+658,342
New +$58M 0.12% 256

Other funds holding ABMD

William Blair Investment Management's ABMD Position: Q4 2022 in Review

William Blair Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 980,662 shares — an estimated $241M sold.

William Blair Investment Management first reported a position in ABMD in Q3 2015 and held it in 29 quarters. The position peaked at $368M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • William Blair Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • William Blair Investment Management sold 980,662 Abiomed Inc shares in Q4 2022, an estimated $241M.
  • William Blair Investment Management first reported a position in Abiomed Inc in Q3 2015 and held it in 29 quarters.
  • William Blair Investment Management's Abiomed Inc position peaked at $368M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on William Blair Investment Management's 13F filing for Q4 2022, filed 9 Feb 2023.